1. Advances in quantum dots as diagnostic tools Ana Soldado, Laura Cid Barrio, María Díaz-Gonzalez, Alfredo de la Escosura-Muñiz, and Jose Manuel Costa-Fernandez 2. Host polymorphisms and COVID-19 infection Joris R. Delanghe and Marijn M. Speeckaert 3. Clinical metabolomics for inborn errors of metabolism Lisa Ford, Matthew Mitchell, Jacob Wulff, Annie Evans, Adam Kennedy, Sarah Elsea, Bryan Wittmann, and Douglas Toal 4. Amino acids in inflammatory bowel diseases: Modern diagnostic tools and methodologies Juraj Piestansky, Dominika Olesova, Michaela Matuskova, Ivana Cizmarova, Petra Chalova, Jaroslav Galba, Petra Majerova, Peter Mikus, and Andrej Kovac 5. Advances in sports genomics Ildus I. Ahmetov, Elliott C.R. Hall, Ekaterina A. Semenova, Erinija Pranckeviciene and Valentina Gineviciene 6. Biomarkers in muscle invasive bladder cancer Fiona Wilson, Nuradh Joseph, and Ananya Choudhury
Dr Gregory S Makowski is a board certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in his joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President and Chief Scientific Officer for Clinical Laboratory Partners in Newington CT, USA.